Global Durvalumab Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

Global Durvalumab Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

  • SKU :
    SAC2031307
  • Published Date :
    July 1, 2022
  • Number of Pages :
    300.0

Product Description

Summary
The report forecast global Durvalumab market to grow to reach xxx Million USD in 2021 with a CAGR of xx% during the period 2022E-2030F due to coronavirus situation.
The report offers detailed coverage of Durvalumab industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Durvalumab  by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
First, this report covers the present status and the future prospects of the global Durvalumab market for 2016-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
At the same time, we classify Durvalumab according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Finally, the report provides detailed profile and data information analysis of leading Durvalumab company.
Key Content of Chapters as follows (Including and can be customized) :
Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Company information, Sales, Cost, Margin etc.
Part 3:
Global Market by company, Type, Application & Geography
Part 4:
Asia-Pacific Market by Type, Application & Geography
Part 5:
Europe Market by Type, Application & Geography
Part 6:
North America Market by Type, Application & Geography
Part 7:
South America Market by Type, Application & Geography
Part 8:
Middle East & Africa Market by Type, Application & Geography
Part 9:
Market Features
Part 10:
Investment Opportunity
Part 11:
Conclusion
Market Segment as follows:
By Region
        Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
        Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
        North America[United States, Canada, Mexico]
        Middle East & Africa[GCC, North Africa, South Africa]
        South America[Brazil, Argentina, Columbia, Chile, Peru]
Key Companies
    Medimmune (AstraZeneca)
Market by Type
    2.4mL Injection
    10mL Injection
Market by Application
    Locally Advanced Urothelial Carcinoma
    Metastatic Urothelial Carcinoma
    Others

Table of Content

Table of Contents
Part 1 Market Overview
    1.1 Market Definition
    1.2 Market Development
        1.2.1 Current Situation
        1.2.2 Aspects of COVID-19 Impact
    1.3 By Type
                Table Type of Durvalumab
                Figure Global Durvalumab Market Share by Type in 2021
    1.4 By Application
                Table Application of Durvalumab
                Figure Global Durvalumab Market Share by Application in 2021
    1.5 By Region
                Figure Global Durvalumab Market Share by Region in 2021
                Figure Asia Durvalumab Market Share by Region in 2021
Part 2 Key Companies
    2.1 Medimmune (AstraZeneca)
        2.1.1 Company Profile
                Table Medimmune (AstraZeneca) Overview List
        2.1.2 Products & Services Overview
        2.1.3 Sales Data List
                Table Durvalumab Business Operation of Medimmune (AstraZeneca) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Part 3 Global Market Status and Future Forecast
    3.1 Global Market by Region
                Table Global Durvalumab Market by Region, 2018-2021 (Million USD)
                Figure Global Durvalumab Market Share by Region in 2021 (Million USD)
                Table Global Durvalumab Market by Region, 2018-2021 (Volume)
                Figure Global Durvalumab Market Share by Region in 2021 (Volume)
                Table Price List by Region, 2018-2021
    3.2 Global Market by Company
                Table Global Durvalumab Market by Company, 2018-2021 (Million USD)
                Figure Global Durvalumab Market Share by Company in 2021 (Million USD)
                Table Global Durvalumab Market by Company, 2018-2021 (Volume)
                Figure Global Durvalumab Market Share by Company in 2021 (Volume)
                Table Price List by Company, 2018-2021
    3.3 Global Market by Type
                Table Global Durvalumab Market by Type, 2018-2021 (Million USD)
                Figure Global Durvalumab Market Share by Type in 2021 (Million USD)
                Table Global Durvalumab Market by Type, 2018-2021 (Volume)
                Figure Global Durvalumab Market Share by Type in 2021 (Volume)
                Table Price List by Type, 2018-2021
    3.4 Global Market by Application
                Table Global Durvalumab Market by Application, 2018-2021 (Million USD)
                Figure Global Durvalumab Market Share by Application in 2021 (Million USD)
                Table Global Durvalumab Market by Application, 2018-2021 (Volume)
                Figure Global Durvalumab Market Share by Application in 2021 (Volume)
                Table Price List by Application, 2018-2021
    3.5 Global Market by Forecast
                Figure Global Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Global Durvalumab Market Forecast, 2022E-2030F (Volume)
Part 4 Asia-Pacific Market Status and Future Forecast
    4.1 Asia-Pacific Market by Type
                Table Asia-Pacific Durvalumab Market by Type, 2018-2021 (Million USD)
                Figure Asia-Pacific Durvalumab Market Share by Type in 2021 (Million USD)
                Table Asia-Pacific Durvalumab Market by Type, 2018-2021 (Volume)
                Figure Asia-Pacific Durvalumab Market Share by Type in 2021 (Volume)
                Table Price List by Type, 2018-2021
    4.2 Asia-Pacific Market by Application
                Table Asia-Pacific Durvalumab Market by Application, 2018-2021 (Million USD)
                Figure Asia-Pacific Durvalumab Market Share by Application in 2021 (Million USD)
                Table Asia-Pacific Durvalumab Market by Application, 2018-2021 (Volume)
                Figure Asia-Pacific Durvalumab Market Share by Application in 2021 (Volume)
                Table Price List by Application, 2018-2021
    4.3 Asia-Pacific Market by Geography
        4.3.1 China Market Status and Future Forecast
                Figure China Durvalumab Market Status, 2018-2021  (Million USD)
                Figure China Durvalumab Market Status, 2018-2021  (Volume)
                Figure China Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure China Durvalumab Market Forecast, 2022E-2030F (Volume)
        4.3.2 Southeast Asia Market Status and Future Forecast
                Figure Southeast Asia Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Southeast Asia Durvalumab Market Status, 2018-2021  (Volume)
                Figure Southeast Asia Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Southeast Asia Durvalumab Market Forecast, 2022E-2030F (Volume)
        4.3.3 India Market Status and Future Forecast
                Figure India Durvalumab Market Status, 2018-2021  (Million USD)
                Figure India Durvalumab Market Status, 2018-2021  (Volume)
                Figure India Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure India Durvalumab Market Forecast, 2022E-2030F (Volume)
        4.3.4 Japan Market Status and Future Forecast
                Figure Japan Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Japan Durvalumab Market Status, 2018-2021  (Volume)
                Figure Japan Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Japan Durvalumab Market Forecast, 2022E-2030F (Volume)
        4.3.5 Korea Market Status and Future Forecast
                Figure Korea Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Korea Durvalumab Market Status, 2018-2021  (Volume)
                Figure Korea Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Korea Durvalumab Market Forecast, 2022E-2030F (Volume)
        4.3.6 Oceania Market Status and Future Forecast
                Figure Oceania Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Oceania Durvalumab Market Status, 2018-2021  (Volume)
                Figure Oceania Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Oceania Durvalumab Market Forecast, 2022E-2030F (Volume)
    4.4 Asia-Pacific Market by Forecast
                Figure Asia-Pacific Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Asia-Pacific Durvalumab Market Forecast, 2022E-2030F (Volume)
Part 5 Europe Market Status and Future Forecast
    5.1 Europe Market by Type
                Table Europe Durvalumab Market by Type, 2018-2021 (Million USD)
                Figure Europe Durvalumab Market Share by Type in 2021 (Million USD)
                Table Europe Durvalumab Market by Type, 2018-2021 (Volume)
                Figure Europe Durvalumab Market Share by Type in 2021 (Volume)
                Table Price List by Type, 2018-2021
    5.2 Europe Market by Application
                Table Europe Durvalumab Market by Application, 2018-2021 (Million USD)
                Figure Europe Durvalumab Market Share by Application in 2021 (Million USD)
                Table Europe Durvalumab Market by Application, 2018-2021 (Volume)
                Figure Europe Durvalumab Market Share by Application in 2021 (Volume)
                Table Price List by Application, 2018-2021
    5.3 Europe Market by Geography
        5.3.1 Germany Market Status and Future Forecast
                Figure Germany Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Germany Durvalumab Market Status, 2018-2021  (Volume)
                Figure Germany Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Germany Durvalumab Market Forecast, 2022E-2030F (Volume)
        5.3.2 UK Market Status and Future Forecast
                Figure UK Durvalumab Market Status, 2018-2021  (Million USD)
                Figure UK Durvalumab Market Status, 2018-2021  (Volume)
                Figure UK Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure UK Durvalumab Market Forecast, 2022E-2030F (Volume)
        5.3.3 France Market Status and Future Forecast
                Figure France Durvalumab Market Status, 2018-2021  (Million USD)
                Figure France Durvalumab Market Status, 2018-2021  (Volume)
                Figure France Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure France Durvalumab Market Forecast, 2022E-2030F (Volume)
        5.3.4 Italy Market Status and Future Forecast
                Figure Italy Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Italy Durvalumab Market Status, 2018-2021  (Volume)
                Figure Italy Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Italy Durvalumab Market Forecast, 2022E-2030F (Volume)
        5.3.5 Russia Market Status and Future Forecast
                Figure Russia Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Russia Durvalumab Market Status, 2018-2021  (Volume)
                Figure Russia Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Russia Durvalumab Market Forecast, 2022E-2030F (Volume)
        5.3.6 Spain Market Status and Future Forecast
                Figure Spain Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Spain Durvalumab Market Status, 2018-2021  (Volume)
                Figure Spain Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Spain Durvalumab Market Forecast, 2022E-2030F (Volume)
        5.3.6 Netherlands Market Status and Future Forecast
                Figure Netherlands Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Netherlands Durvalumab Market Status, 2018-2021  (Volume)
                Figure Netherlands Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Netherlands Durvalumab Market Forecast, 2022E-2030F (Volume)
        5.3.7 Turkey Market Status and Future Forecast
                Figure Turkey Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Turkey Durvalumab Market Status, 2018-2021  (Volume)
                Figure Turkey Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Turkey Durvalumab Market Forecast, 2022E-2030F (Volume)
        5.3.6 Switzerland Market Status and Future Forecast
                Figure Switzerland Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Switzerland Durvalumab Market Status, 2018-2021  (Volume)
                Figure Switzerland Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Switzerland Durvalumab Market Forecast, 2022E-2030F (Volume)
    5.4 Europe Market by Forecast
                Figure Europe Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Europe Durvalumab Market Forecast, 2022E-2030F (Volume)
Part 6 North America Market Status and Future Forecast
    6.1 North America Market by Type
                Table North America Durvalumab Market by Type, 2018-2021 (Million USD)
                Figure North America Durvalumab Market Share by Type in 2021 (Million USD)
                Table North America Durvalumab Market by Type, 2018-2021 (Volume)
                Figure North America Durvalumab Market Share by Type in 2021 (Volume)
                Table Price List by Type, 2018-2021
    6.2 North America Market by Application
                Table North America Durvalumab Market by Application, 2018-2021 (Million USD)
                Figure North America Durvalumab Market Share by Application in 2021 (Million USD)
                Table North America Durvalumab Market by Application, 2018-2021 (Volume)
                Figure North America Durvalumab Market Share by Application in 2021 (Volume)
                Table Price List by Application, 2018-2021
    6.3 North America Market by Geography
        6.3.1 United States Market Status and Future Forecast
                Figure United States Durvalumab Market Status, 2018-2021  (Million USD)
                Figure United States Durvalumab Market Status, 2018-2021  (Volume)
                Figure United States Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure United States Durvalumab Market Forecast, 2022E-2030F (Volume)
        6.3.2 Canada Market Status and Future Forecast
                Figure Canada Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Canada Durvalumab Market Status, 2018-2021  (Volume)
                Figure Canada Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Canada Durvalumab Market Forecast, 2022E-2030F (Volume)
        6.3.3 Mexico Market Status and Future Forecast
                Figure Mexico Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Mexico Durvalumab Market Status, 2018-2021  (Volume)
                Figure Mexico Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Mexico Durvalumab Market Forecast, 2022E-2030F (Volume)
    6.4 North America Market by Forecast
                Figure North America Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure North America Durvalumab Market Forecast, 2022E-2030F (Volume)
Part 7 South America Market Status and Future Forecast
    7.1 South America Market by Type
                Table South America Durvalumab Market by Type, 2018-2021 (Million USD)
                Figure South America Durvalumab Market Share by Type in 2021 (Million USD)
                Table South America Durvalumab Market by Type, 2018-2021 (Volume)
                Figure South America Durvalumab Market Share by Type in 2021 (Volume)
                Table Price List by Type, 2018-2021
    7.2 South America Market by Application
                Table South America Durvalumab Market by Application, 2018-2021 (Million USD)
                Figure South America Durvalumab Market Share by Application in 2021 (Million USD)
                Table South America Durvalumab Market by Application, 2018-2021 (Volume)
                Figure South America Durvalumab Market Share by Application in 2021 (Volume)
                Table Price List by Application, 2018-2021
    7.3 South America Market by Geography
        7.3.1 Brazil Market Status and Future Forecast
                Figure Brazil Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Brazil Durvalumab Market Status, 2018-2021  (Volume)
                Figure Brazil Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Brazil Durvalumab Market Forecast, 2022E-2030F (Volume)
        7.3.2 Argentina Market Status and Future Forecast
                Figure Argentina Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Argentina Durvalumab Market Status, 2018-2021  (Volume)
                Figure Argentina Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Argentina Durvalumab Market Forecast, 2022E-2030F (Volume)
        7.3.3 Columbia Market Status and Future Forecast
                Figure Columbia Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Columbia Durvalumab Market Status, 2018-2021  (Volume)
                Figure Columbia Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Columbia Durvalumab Market Forecast, 2022E-2030F (Volume)
        7.3.4 Chile Market Status and Future Forecast
                Figure Chile Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Chile Durvalumab Market Status, 2018-2021  (Volume)
                Figure Chile Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Chile Durvalumab Market Forecast, 2022E-2030F (Volume)
        7.3.5 Peru Market Status and Future Forecast
                Figure Peru Durvalumab Market Status, 2018-2021  (Million USD)
                Figure Peru Durvalumab Market Status, 2018-2021  (Volume)
                Figure Peru Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Peru Durvalumab Market Forecast, 2022E-2030F (Volume)
    7.4 South America Market by Forecast
                Figure South America Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure South America Durvalumab Market Forecast, 2022E-2030F (Volume)
Part 8 Middle East & Africa Market Status and Future Forecast
    8.1 Middle East & Africa Market by Type
                Table Middle East & Africa Durvalumab Market by Type, 2018-2021 (Million USD)
                Figure Middle East & Africa Durvalumab Market Share by Type in 2021 (Million USD)
                Table Middle East & Africa Durvalumab Market by Type, 2018-2021 (Volume)
                Figure Middle East & Africa Durvalumab Market Share by Type in 2021 (Volume)
                Table Price List by Type, 2018-2021
    8.2 Middle East & Africa Market by Application
                Table Middle East & Africa Durvalumab Market by Application, 2018-2021 (Million USD)
                Figure Middle East & Africa Durvalumab Market Share by Application in 2021 (Million USD)
                Table Middle East & Africa Durvalumab Market by Application, 2018-2021 (Volume)
                Figure Middle East & Africa Durvalumab Market Share by Application in 2021 (Volume)
                Table Price List by Application, 2018-2021
    8.3 Middle East & Africa Market by Geography
        8.3.1 GCC Market Status and Future Forecast
                Figure GCC Durvalumab Market Status, 2018-2021  (Million USD)
                Figure GCC Durvalumab Market Status, 2018-2021  (Volume)
                Figure GCC Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure GCC Durvalumab Market Forecast, 2022E-2030F (Volume)
        8.3.2 North Africa Market Status and Future Forecast
                Figure North Africa Durvalumab Market Status, 2018-2021  (Million USD)
                Figure North Africa Durvalumab Market Status, 2018-2021  (Volume)
                Figure North Africa Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure North Africa Durvalumab Market Forecast, 2022E-2030F (Volume)
        8.3.3 South Africa Market Status and Future Forecast
                Figure South Africa Durvalumab Market Status, 2018-2021  (Million USD)
                Figure South Africa Durvalumab Market Status, 2018-2021  (Volume)
                Figure South Africa Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure South Africa Durvalumab Market Forecast, 2022E-2030F (Volume)
    8.4 Middle East & Africa Market by Forecast
                Figure Middle East & Africa Durvalumab Market Forecast, 2022E-2030F (Million USD)
                Figure Middle East & Africa Durvalumab Market Forecast, 2022E-2030F (Volume)
Part 9 Market Features
    9.1 Product Features
    9.2 Price Features
    9.3 Channel Features
    9.4 Purchasing Features
Part 10 Investment Opportunity
    10.1 Regional Investment Opportunity
    10.2 Industry Investment Opportunity
PART 11 Coronavirus Impact
    11.1 Impact on Industry Upstream
    11.2 Impact on Industry Downstream
    11.3 Impact on Industry Channels
    11.4 Impact on Industry Competition
    11.5 Impact on Industry Obtain Employment
Part 12 Conclusion

Search results for Pharmaceutical Industry

Select License Type